Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

NCT: NCT05416086 · TERMINATED

NCT IDNCT05416086
StatusTERMINATED
Start Date2021-09-03
Completion2025-01-28

Brief Summary

A prospective, single-arm, multi-center study designed to collect real world safety and performance data of the Adagio Medical iCLAS Cryoablation System in the treatment of drug refractory, recurrent, symptomatic, Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation (PsAF), and Atrial Flutter (AFL).

Frequently Asked Questions

What is iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study?

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study is a clinical trial registered under NCT05416086. Current status: TERMINATED.

What is the status of NCT05416086?

The current status of NCT05416086 (iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study) is: TERMINATED.

When did iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study start?

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study started on 2021-09-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑